Stock Fundamentals

Company Information

Company Name
Dr. Reddy’s Laboratories Ltd ADR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
ISIN: US2561352038
CIK: 0001135951
CUSIP: 256135203
Currency: USD
Full Time Employees: 27,527
Phone: 91 40 4900 2900
Fiscal Year End: March
IPO Date: Apr 11, 2001
Description:

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Address:

8-2-337, Road No. 3, Hyderabad, India, 500034

Directors & Officers

Name Title Year Born
Mr. Gunupati Venkateswara Prasad B.E. Co-Chairman, MD & Member of Management Council 1960
Mr. Kallam Satish Reddy B.Tech., M.S. Chairman of the Board & Member of the Management Council 1967
Mr. Erez Israeli M.B.A. CEO & Member of the Management Council 1968
Mr. Mannam Venkatanarasimham CFO & Member of the Management Council 1970
Mr. Krishna K. Venkatesh B.Pharma M.S. Global Head of IPDO, Integrated Product Development & Member of the Management Council 1973
Mr. Deepak Sapra M.B.A. Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council 1975
Mr. Motupalli Venkata Ramana M.B.A. CEO of Global Generics & Member of Management Council 1969
Mr. Sanjay Sharma B.Tech. Executive VP, COO & Member of Management Council 1968
Mr. Patrick Aghanian B.A., M.B.A. Head of Consumer Health Organization & Member of Management Council 1965
Mr. Bhethanabottla S. Phanimitra Chief Digital & Information Officer and Member of the Management Council 1980

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Robeco Institutional Asset Management BV 17.18M Mar 31, 2026 2.06% $0.34 30.59%
BlackRock Inc 11.59M Mar 31, 2026 1.39% $0.00 12.52%
Royal Bank of Canada 9.98M Mar 31, 2026 1.20% $0.02 4.55%
Morgan Stanley - Brokerage Accounts 9.37M Mar 31, 2026 1.13% $0.01 4.99%
Aikya Investment Management Ltd 8.00M Mar 31, 2026 0.96% $32.14 9.01%
Renaissance Technologies Corp 7.86M Mar 31, 2026 0.94% $0.17 -4.79%
Dimensional Fund Advisors, Inc. 5.32M Mar 31, 2026 0.64% $0.02 -0.63%
Vanguard Group Inc 5.03M Dec 31, 2025 0.60% $0.00 -1.88%
JPMorgan Chase & Co 4.37M Mar 31, 2026 0.53% $0.00 -20.05%
State Street Corp 4.03M Mar 31, 2026 0.48% $0.00 0.93%
BNP Paribas Arbitrage, SA 3.18M Mar 31, 2026 0.38% $0.02 -23.33%
Vanguard Capital Management, LLC 3.10M Mar 31, 2026 0.37% $0.00 0.00%
Franklin Resources Inc 2.86M Mar 31, 2026 0.34% $0.01 0.00%
Marshall Wace Asset Management Ltd 2.66M Mar 31, 2026 0.32% $0.04 416.08%
AllianceBernstein L.P. 2.54M Mar 31, 2026 0.31% $0.01 8,383.99%
Acadian Asset Management LLC 2.41M Mar 31, 2026 0.29% $0.05 77,828.21%
Bessemer Group Inc 1.82M Mar 31, 2026 0.22% $0.04 28.39%
Vanguard Portfolio Management, LLC 1.77M Mar 31, 2026 0.21% $0.00 0.00%
American Century Companies Inc 1.66M Mar 31, 2026 0.20% $0.01 22.94%
UBS Group AG 1.55M Mar 31, 2026 0.19% $0.00 57.36%

Shares Statistics

Shares Outstanding: 832.70M
Shares Float: 3.59B
% Insiders: 0.00%
% Institutions: 1,529.20%
Short % Float: 3.26%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 RBC Emerging Markets Equity Fund F 5.43M 0.65% ▲ 0.00% Mar 31, 2026
2 RBC Emerging Markets Equity 5.43M 0.65% ▲ 0.00% Mar 31, 2026
3 Robeco QI EM Active Equities I € 2.56M 0.31% ▲ 7.46% Apr 30, 2026
4 Robeco QI Emerging Cnsrv Eqs I € 2.18M 0.26% ▲ 0.00% Apr 30, 2026
5 Vanguard Emerging Mkts Stock Idx Inv 1.87M 0.23% ▲ 0.00% Apr 30, 2026
6 Vanguard Global Minimum Volatility Admr 1.77M 0.21% ▲ 6.47% Mar 31, 2026
7 Avantis Emerging Markets Equity ETF 1.72M 0.21% ▲ 0.00% May 30, 2026
8 State Street® SPDR® Portfolio EM ETF 1.48M 0.18% ▲ 0.00% May 29, 2026
9 DFA Emerging Markets Core Equity 2 I 1.35M 0.16% ▲ 0.00% Mar 31, 2026
10 Vanguard Total Intl Stock Index Inv 874.07K 0.11% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $10.97B
Trailing P/E: 24.63
Forward P/E: 24.94

Financial Highlights

Market Cap: $11.07B
EBITDA: $68.15B
P/E Ratio: $24.63
PEG Ratio: $1.61
Book Value: $0.79
Dividend/Share: $8.00
Dividend Yield: 0.63%
Earnings/Share: $0.54
Profit Margin: 12.76%
Operating Margin: 1.54%
ROA (TTM): 5.74%
ROE (TTM): 11.84%
Revenue (TTM): $335.93B
Revenue/Share (TTM): $67.39
Earnings Growth (YOY): -86.20%
Revenue Growth (YOY): -11.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2026-03-31 1.80x 0.21x 0.34x 12.42x 0.91x
2025-03-31 1.92x 0.13x 0.32x 25.40x 0.44x
2024-03-31 2.58x 0.06x 0.28x 39.58x 0.20x
2023-03-31 2.38x 0.05x 0.28x 40.02x 0.16x
2022-03-31 1.93x 0.18x 0.35x 30.77x 0.75x
2021-03-31 1.78x 2.80x 0.35x 0.44x 12.39x
2020-03-31 1.79x 0.13x 0.33x 1,153.61x 0.01x
2019-03-31 1.92x 0.27x 0.38x 23.50x 1.06x
2018-03-31 1.57x 0.40x 0.44x 15.12x 2.12x
2017-03-31 1.18x 0.39x 0.44x 21.29x 1.96x
2016-03-31 1.85x 0.26x 0.38x 35.86x 0.82x
2015-03-31 1.87x 0.26x 0.43x 24.07x 0.84x
2014-03-31 1.92x 0.27x 0.47x 20.43x 0.73x
2013-03-31 1.60x 0.03x 0.49x 20.74x 1.08x
2012-03-31 1.61x 0.28x 0.52x 17.11x 0.80x
2011-03-31 1.16x 0.40x 0.52x 34.88x 1.09x
2010-03-31 1.45x 0.22x 0.47x 5.40x 1.43x
2009-03-31 1.47x 0.23x 0.50x -1.70x 6.57x
2008-03-31 1.79x 0.15x 0.45x 3.11x 0.96x
2007-03-31 2.02x 0.10x 0.52x N/A 0.29x
2006-03-31 0.82x 0.47x 0.68x N/A 3.90x
2005-03-31 2.42x 0.13x 0.28x N/A 2.75x
2004-03-31 3.43x 0.02x 0.21x N/A 0.17x
2003-03-31 4.87x 0.02x 0.18x N/A 0.07x
2002-03-31 5.03x 0.01x 0.19x N/A 0.02x
2001-03-31 1.18x 0.57x 0.56x N/A 1.24x
2000-03-31 0.00x 0.25x 0.36x N/A 1.43x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RDY.US!